According to Market IntelliX Research, the global market for Meglinitide should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Meglinitide market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Meglinitide market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Repaglinide segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Type II Diabetes has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Meglinitide include Pfizer Inc, F. Hoffmann-La Roche Ltd, Mylan N.V, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Novartis AG, Teva Pharmaceutical Industries Ltd., Bristol Myers Squibb Company and GSK Plc, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
Meglinitides are the agents used to treat type 2 diabetes. They act same as β-cell receptor as sulphonylureas, but have a different chemical structure. They are novel class of non-sulfonylurea insulin secretagogues characterized by very rapid onset and abbreviated duration of action. They act by stimulating pancreas to release insulin in response to meal. In functioning pancreatic beta cells, it also closes ATP-dependent potassium dependent channels. Due to this depolarization of beta cells, opening of calcium channels resulting in influx of calcium and Increased intracellular calcium induces insulin secretion.
This report aims to provide a comprehensive study of the global market for Meglinitide. Report Highlights:
(1) Global Meglinitide market size (sales volume & revenue),history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Meglinitide market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Meglinitide market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Meglinitide segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Meglinitide segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Meglinitide, capacity, production and trends.
(7) Meglinitide industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Repaglinide
Nateglinide
Other
Market segment by application, can be divided into
Type II Diabetes
Others
Market segment by players, this report covers
Pfizer Inc
F. Hoffmann-La Roche Ltd
Mylan N.V
Fresenius Kabi AG
Hikma Pharmaceuticals PLC
Novartis AG
Teva Pharmaceutical Industries Ltd.
Bristol Myers Squibb Company
GSK Plc
Bayer AG
Sun Pharmaceutical Industries Ltd
Novartis AG
Lupin
Cipla Inc
Aurobindo Pharma
1 Market Overview
1.1 Meglinitide Definition
1.2 Global Meglinitide Market Size and Forecast
1.2.1 By Revenue, Global Meglinitide Market Size, 2019-2030
1.2.2 By Sales Volume, Global Meglinitide Market Size, 2019-2030
1.2.3 Global Meglinitide Price Trend, 2019-2030
1.3 China Meglinitide Market Size and Forecast
1.3.1 By Revenue, China Meglinitide Market Size, 2019-2030
1.3.2 By Sales Volume, China Meglinitide Market Size, 2019-2030
1.3.3 China Meglinitide Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Meglinitide Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Meglinitide Share in Global Market, 2019-2030
1.4.3 Meglinitide Market Size: China VS Global, 2019-2030
1.5 Meglinitide Market Dynamics
1.5.1 Meglinitide Market Drivers
1.5.2 Meglinitide Market Restraints
1.5.3 Meglinitide Industry Trends
1.5.4 Meglinitide Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Meglinitide Revenue by Company, 2019-2024
2.2 Global Meglinitide Sales Volume by Company, 2019-2024
2.3 Global Meglinitide Price by Company, 2019-2024
2.4 Global Meglinitide Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Meglinitide Concentration Ratio
2.6 Global Meglinitide Mergers & Acquisitions, Expansion Plans
2.7 Global Meglinitide Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Meglinitide Revenue by Company, 2019-2024
3.2 China Meglinitide Sales Volume by Company, 2019-2024
3.3 China Meglinitide Meglinitide Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Meglinitide Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Meglinitide Domestic VS Export
3.6 China Market, Meglinitide Import & Export
3.6.1 China Market, Meglinitide Import & Export, 2019-2030
3.6.2 China Meglinitide Import & Export Trends
3.6.3 Main Sources of China Meglinitide Import
3.6.4 Export Destination of China Meglinitide
4 Meglinitide Production by Region
4.1 Global Meglinitide Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Meglinitide Manufacturers
4.3 Global Major Manufacturers, Meglinitide Capacity Expansion and Future Plans
4.4 Global Meglinitide Capacity by Region
4.5 Global Meglinitide Production by Region
4.5.1 Global Meglinitide Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Meglinitide Production by Region, 2019-2024
4.5.3 Global Meglinitide Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Meglinitide Industry Chain
5.2 Meglinitide Upstream Analysis
5.2.1 Meglinitide Core Raw Materials
5.2.2 Main Manufacturers of Meglinitide Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Meglinitide Production Mode
5.6 Meglinitide Procurement Model
5.7 Meglinitide Industry Sales Model and Sales Channels
5.7.1 Meglinitide Sales Model
5.7.2 Meglinitide Typical Distributors
6 Sights by Type
6.1 Meglinitide Classification
6.1.1 Repaglinide
6.1.2 Nateglinide
6.1.3 Other
6.2 By Type, Global Meglinitide Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Meglinitide Revenue, 2019-2030
6.4 By Type, Global Meglinitide Sales Volume, 2019-2030
6.5 By Type, Global Meglinitide Price, 2019-2030
7 Sights by Application
7.1 Meglinitide Segment by Application
7.1.1 Type II Diabetes
7.1.2 Others
7.2 By Application, Global Meglinitide Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Meglinitide Revenue, 2019-2030
7.4 By Application, Global Meglinitide Sales Volume, 2019-2030
7.5 By Application, Global Meglinitide Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Meglinitide Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Meglinitide Revenue, 2019-2030
8.3 By Region, Global Meglinitide Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Meglinitide Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Meglinitide Market Size Market Share
8.5 Europe
8.5.1 Europe Meglinitide Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Meglinitide Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Meglinitide Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Meglinitide Market Size Market Share
8.7 South America
8.7.1 South America Meglinitide Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Meglinitide Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Meglinitide Market Size & CAGR,2019 VS 2024 VS 2030
9.2 By Country, Global Meglinitide Revenue, 2019-2030
9.3 By Country, Global Meglinitide Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Meglinitide Market Size, 2019-2030
9.4.2 By Company, U.S. Meglinitide Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Meglinitide Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Meglinitide Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Meglinitide Market Size, 2019-2030
9.5.2 By Company, Europe Meglinitide Sales Volume Market Share, 2023
9.5.3 By Type, Europe Meglinitide Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Meglinitide Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Meglinitide Market Size, 2019-2030
9.6.2 By Company, China Meglinitide Sales Volume Market Share, 2023
9.6.3 By Type, China Meglinitide Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Meglinitide Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Meglinitide Market Size, 2019-2030
9.7.2 By Company, Japan Meglinitide Sales Volume Market Share, 2023
9.7.3 By Type, Japan Meglinitide Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Meglinitide Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Meglinitide Market Size, 2019-2030
9.8.2 By Company, South Korea Meglinitide Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Meglinitide Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Meglinitide Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Meglinitide Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Meglinitide Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Meglinitide Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Meglinitide Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Meglinitide Market Size, 2019-2030
9.10.2 By Company, India Meglinitide Sales Volume Market Share, 2023
9.10.3 By Type, India Meglinitide Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Meglinitide Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Meglinitide Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Meglinitide Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Meglinitide Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Meglinitide Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Pfizer Inc
10.1.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer Inc Meglinitide Models, Specifications and Application
10.1.3 Pfizer Inc Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Pfizer Inc Company Profile and Main Business
10.1.5 Pfizer Inc Recent Developments
10.2 F. Hoffmann-La Roche Ltd
10.2.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.2.2 F. Hoffmann-La Roche Ltd Meglinitide Models, Specifications and Application
10.2.3 F. Hoffmann-La Roche Ltd Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.2.5 F. Hoffmann-La Roche Ltd Recent Developments
10.3 Mylan N.V
10.3.1 Mylan N.V Company Information, Head Office, Market Area and Industry Position
10.3.2 Mylan N.V Meglinitide Models, Specifications and Application
10.3.3 Mylan N.V Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Mylan N.V Company Profile and Main Business
10.3.5 Mylan N.V Recent Developments
10.4 Fresenius Kabi AG
10.4.1 Fresenius Kabi AG Company Information, Head Office, Market Area and Industry Position
10.4.2 Fresenius Kabi AG Meglinitide Models, Specifications and Application
10.4.3 Fresenius Kabi AG Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Fresenius Kabi AG Company Profile and Main Business
10.4.5 Fresenius Kabi AG Recent Developments
10.5 Hikma Pharmaceuticals PLC
10.5.1 Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
10.5.2 Hikma Pharmaceuticals PLC Meglinitide Models, Specifications and Application
10.5.3 Hikma Pharmaceuticals PLC Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Hikma Pharmaceuticals PLC Company Profile and Main Business
10.5.5 Hikma Pharmaceuticals PLC Recent Developments
10.6 Novartis AG
10.6.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.6.2 Novartis AG Meglinitide Models, Specifications and Application
10.6.3 Novartis AG Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Novartis AG Company Profile and Main Business
10.6.5 Novartis AG Recent Developments
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
10.7.2 Teva Pharmaceutical Industries Ltd. Meglinitide Models, Specifications and Application
10.7.3 Teva Pharmaceutical Industries Ltd. Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
10.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.8 Bristol Myers Squibb Company
10.8.1 Bristol Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.8.2 Bristol Myers Squibb Company Meglinitide Models, Specifications and Application
10.8.3 Bristol Myers Squibb Company Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Bristol Myers Squibb Company Company Profile and Main Business
10.8.5 Bristol Myers Squibb Company Recent Developments
10.9 GSK Plc
10.9.1 GSK Plc Company Information, Head Office, Market Area and Industry Position
10.9.2 GSK Plc Meglinitide Models, Specifications and Application
10.9.3 GSK Plc Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 GSK Plc Company Profile and Main Business
10.9.5 GSK Plc Recent Developments
10.10 Bayer AG
10.10.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.10.2 Bayer AG Meglinitide Models, Specifications and Application
10.10.3 Bayer AG Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Bayer AG Company Profile and Main Business
10.10.5 Bayer AG Recent Developments
10.11 Sun Pharmaceutical Industries Ltd
10.11.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.11.2 Sun Pharmaceutical Industries Ltd Meglinitide Models, Specifications and Application
10.11.3 Sun Pharmaceutical Industries Ltd Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.12 Novartis AG
10.12.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.12.2 Novartis AG Meglinitide Models, Specifications and Application
10.12.3 Novartis AG Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Novartis AG Company Profile and Main Business
10.12.5 Novartis AG Recent Developments
10.13 Lupin
10.13.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.13.2 Lupin Meglinitide Models, Specifications and Application
10.13.3 Lupin Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Lupin Company Profile and Main Business
10.13.5 Lupin Recent Developments
10.14 Cipla Inc
10.14.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.14.2 Cipla Inc Meglinitide Models, Specifications and Application
10.14.3 Cipla Inc Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Cipla Inc Company Profile and Main Business
10.14.5 Cipla Inc Recent Developments
10.15 Aurobindo Pharma
10.15.1 Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
10.15.2 Aurobindo Pharma Meglinitide Models, Specifications and Application
10.15.3 Aurobindo Pharma Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.15.4 Aurobindo Pharma Company Profile and Main Business
10.15.5 Aurobindo Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Meglinitide Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Meglinitide Market Restraints
Table 3. Meglinitide Market Trends
Table 4. Meglinitide Industry Policy
Table 5. Global Meglinitide Revenue by Company, 2019-2024, US$ million
Table 6. Global Meglinitide Revenue Market Share by Company, 2019-2024
Table 7. Global Meglinitide Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Meglinitide Sales Volume Market Share by Company, 2019-2024
Table 9. Global Meglinitide Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Meglinitide Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Meglinitide Mergers & Acquisitions, Expansion Plans
Table 12. Global Meglinitide Manufacturers Product Type
Table 13. China Meglinitide Revenue by Company, 2019-2024, US$ million
Table 14. China Meglinitide Revenue Market Share by Company, 2019-2024
Table 15. China Meglinitide Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Meglinitide Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Meglinitide Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Meglinitide Import & Export Trends
Table 19. Main Sources of China Meglinitide Import
Table 20. Export Destination of China Meglinitide
Table 21. Global Headquarters and Manufacturing Base of Meglinitide Manufacturers
Table 22. Global Major Manufacturers, Meglinitide Capacity Expansion and Future Plans
Table 23. Global Meglinitide Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Meglinitide Production by Region, 2019-2024, (K Units)
Table 25. Global Meglinitide Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Meglinitide Upstream (Raw Materials)
Table 27. Global Meglinitide Typical Customers
Table 28. Meglinitide Typical Distributors
Table 29. By Type, Global Meglinitide Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Meglinitide Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Meglinitide Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Meglinitide Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Meglinitide Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Meglinitide Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Meglinitide Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Meglinitide Revenue Market Share, 2019-2030
Table 37. By Country, Global Meglinitide Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Meglinitide Sales Volume Market Share, 2019-2030
Table 39. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 40. Pfizer Inc Meglinitide Models, Specifications and Application
Table 41. Pfizer Inc Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Pfizer Inc Company Profile and Main Business
Table 43. Pfizer Inc Recent Developments
Table 44. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 45. F. Hoffmann-La Roche Ltd Meglinitide Models, Specifications and Application
Table 46. F. Hoffmann-La Roche Ltd Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 48. F. Hoffmann-La Roche Ltd Recent Developments
Table 49. Mylan N.V Company Information, Head Office, Market Area and Industry Position
Table 50. Mylan N.V Meglinitide Models, Specifications and Application
Table 51. Mylan N.V Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Mylan N.V Company Profile and Main Business
Table 53. Mylan N.V Recent Developments
Table 54. Fresenius Kabi AG Company Information, Head Office, Market Area and Industry Position
Table 55. Fresenius Kabi AG Meglinitide Models, Specifications and Application
Table 56. Fresenius Kabi AG Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Fresenius Kabi AG Company Profile and Main Business
Table 58. Fresenius Kabi AG Recent Developments
Table 59. Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
Table 60. Hikma Pharmaceuticals PLC Meglinitide Models, Specifications and Application
Table 61. Hikma Pharmaceuticals PLC Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Hikma Pharmaceuticals PLC Company Profile and Main Business
Table 63. Hikma Pharmaceuticals PLC Recent Developments
Table 64. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 65. Novartis AG Meglinitide Models, Specifications and Application
Table 66. Novartis AG Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Novartis AG Company Profile and Main Business
Table 68. Novartis AG Recent Developments
Table 69. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
Table 70. Teva Pharmaceutical Industries Ltd. Meglinitide Models, Specifications and Application
Table 71. Teva Pharmaceutical Industries Ltd. Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
Table 73. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 74. Bristol Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
Table 75. Bristol Myers Squibb Company Meglinitide Models, Specifications and Application
Table 76. Bristol Myers Squibb Company Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Bristol Myers Squibb Company Company Profile and Main Business
Table 78. Bristol Myers Squibb Company Recent Developments
Table 79. GSK Plc Company Information, Head Office, Market Area and Industry Position
Table 80. GSK Plc Meglinitide Models, Specifications and Application
Table 81. GSK Plc Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. GSK Plc Company Profile and Main Business
Table 83. GSK Plc Recent Developments
Table 84. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 85. Bayer AG Meglinitide Models, Specifications and Application
Table 86. Bayer AG Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Bayer AG Company Profile and Main Business
Table 88. Bayer AG Recent Developments
Table 89. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 90. Sun Pharmaceutical Industries Ltd Meglinitide Models, Specifications and Application
Table 91. Sun Pharmaceutical Industries Ltd Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 93. Sun Pharmaceutical Industries Ltd Recent Developments
Table 94. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 95. Novartis AG Meglinitide Models, Specifications and Application
Table 96. Novartis AG Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Novartis AG Company Profile and Main Business
Table 98. Novartis AG Recent Developments
Table 99. Lupin Company Information, Head Office, Market Area and Industry Position
Table 100. Lupin Meglinitide Models, Specifications and Application
Table 101. Lupin Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Lupin Company Profile and Main Business
Table 103. Lupin Recent Developments
Table 104. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 105. Cipla Inc Meglinitide Models, Specifications and Application
Table 106. Cipla Inc Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. Cipla Inc Company Profile and Main Business
Table 108. Cipla Inc Recent Developments
Table 109. Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
Table 110. Aurobindo Pharma Meglinitide Models, Specifications and Application
Table 111. Aurobindo Pharma Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 112. Aurobindo Pharma Company Profile and Main Business
Table 113. Aurobindo Pharma Recent Developments
List of Figure
Figure 1. Meglinitide Picture
Figure 2. By Revenue, Global Meglinitide Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Meglinitide Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Meglinitide Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Meglinitide Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Meglinitide Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Meglinitide Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Meglinitide Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Meglinitide Share of Global Market, 2019-2030
Figure 10. Global Meglinitide Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Meglinitide Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Meglinitide Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Meglinitide Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Meglinitide Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Meglinitide Domestic VS Export, 2022
Figure 16. Global Meglinitide Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Meglinitide Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Meglinitide Production Market Share & Forecast by Region, 2019-2030
Figure 19. Meglinitide Industry Chain
Figure 20. Meglinitide Procurement Model
Figure 21. Meglinitide Sales Model
Figure 22. Meglinitide Sales Channels, Direct Sales and Distribution
Figure 23. Repaglinide
Figure 24. Nateglinide
Figure 25. Other
Figure 26. By Type, Global Meglinitide Revenue, 2019-2030, US$ Million
Figure 27. By Type, Global Meglinitide Revenue Market Share, 2019-2030
Figure 28. By Type, Global Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 29. By Type, Global Meglinitide Sales Volume Market Share, 2019-2030
Figure 30. By Type, Global Meglinitide Price, 2019-2030, (US$/Unit)
Figure 31. Type II Diabetes
Figure 32. Others
Figure 33. By Application, Global Meglinitide Revenue, 2019-2030, US$ Million
Figure 34. By Application, Global Meglinitide Revenue Market Share, 2019-2030
Figure 35. By Application, Global Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 36. By Application, Global Meglinitide Sales Volume Market Share, 2019-2030
Figure 37. By Application, Global Meglinitide Price, 2019-2030, (US$/Unit)
Figure 38. By Region, Global Meglinitide Revenue Market Share, 2019-2030
Figure 39. By Region, Global Meglinitide Sales Volume Market Share, 2019-2030
Figure 40. North America Meglinitide Revenue & Forecasts, 2019-2030, US$ Million
Figure 41. By Country, North America Meglinitide Revenue Market Share, 2022
Figure 42. Europe Meglinitide Revenue & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, Europe Meglinitide Revenue Market Share, 2022
Figure 44. Asia Pacific Meglinitide Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country/Region, Asia Pacific Meglinitide Revenue Market Share, 2022
Figure 46. South America Meglinitide Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, South America Meglinitide Revenue Market Share, 2022
Figure 48. Middle East & Africa Meglinitide Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. U.S. Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 50. By Company, U.S. Meglinitide Market Share, 2022
Figure 51. By Type, U.S. Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 54. By Company, Europe Meglinitide Market Share, 2022
Figure 55. By Type, Europe Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 57. China Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 58. By Company, China Meglinitide Market Share, 2022
Figure 59. By Type, China Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 62. By Company, Japan Meglinitide Market Share, 2022
Figure 63. By Type, Japan Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 66. By Company, South Korea Meglinitide Market Share, 2022
Figure 67. By Type, South Korea Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 70. By Company, Southeast Asia Meglinitide Market Share, 2022
Figure 71. By Type, Southeast Asia Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 73. India Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 74. By Company, India Meglinitide Market Share, 2022
Figure 75. By Type, India Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Meglinitide Sales Volume, 2019-2030, (K Units)
Figure 78. By Company, Middle East & Asia Meglinitide Market Share, 2022
Figure 79. By Type, Middle East & Asia Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, Middle East & Asia Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|